Prostate Carcinoma Clinical Trials in San Francisco, California

13 recruitingSan Francisco, California

Showing 113 of 13 trials

Recruiting
Early Phase 1

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

Prostate CancerLocalized Prostate Carcinoma
Ivan de Kouchkovsky, MD80 enrolled1 locationNCT02526368
Recruiting
Phase 2

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Prostate CancerProstate CarcinomaMetastatic Castration-resistant Prostate Cancer+1 more
University of California, San Francisco48 enrolled1 locationNCT05766371
Recruiting
Phase 1Phase 2

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Castration-Resistant Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8+2 more
Vadim S Koshkin30 enrolled1 locationNCT05113537
Recruiting
Phase 3

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Stage IVB Prostate Cancer AJCC v8Metastatic Prostate AdenocarcinomaCastration-Sensitive Prostate Carcinoma
Alliance for Clinical Trials in Oncology1,260 enrolled177 locationsNCT06931340
Recruiting
Phase 1

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Prostate CancerLocalized Prostate CarcinomaHigh-risk Prostate Cancer+2 more
Thomas Hope45 enrolled1 locationNCT07054346
Recruiting
Phase 2

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Stage IVB Prostate Cancer AJCC v8Metastatic Castration-Resistant Prostate Carcinoma
University of Washington51 enrolled3 locationsNCT06526299
Recruiting
Not Applicable

Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer

Prostate CancerAdvanced Prostate Carcinoma
University of California, San Francisco250 enrolled1 locationNCT05396872
Recruiting
Phase 2

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

Prostate CancerHigh Risk Prostate Carcinoma
Ivan de Kouchkovsky, MD32 enrolled1 locationNCT06384222
Recruiting
Not Applicable

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Prostate Carcinoma
University of California, San Francisco72 enrolled3 locationsNCT04763980
Recruiting

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

Prostate Carcinoma
University of Washington450 enrolled8 locationsNCT04472338
Recruiting
Phase 1

Imaging of Solid Tumors Using 18F-TRX

Metastatic Malignant Solid NeoplasmStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+7 more
Rahul Aggarwal56 enrolled1 locationNCT06942104
Recruiting
Not Applicable

Two-fraction HDR Monotherapy for Localized Prostate Cancer

Prostate AdenocarcinomaLocalized Prostate Carcinoma
University of California, San Francisco17 enrolled1 locationNCT05665738
Recruiting
Phase 2

Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer

Prostate CancerAdvanced Prostate Carcinoma
Ivan de Kouchkovsky, MD75 enrolled1 locationNCT04346225